Temple Health helping chronic bronchitis patients breath again with RheOx patient trials
Final trials are underway at Temple Health for RheOx, a minimally invasive treatment for chronic bronchitis.
Stay updated with breaking news from Nathaniel Marchetti. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Final trials are underway at Temple Health for RheOx, a minimally invasive treatment for chronic bronchitis.
Many people have a lingering cough after a COVID infection. Experts explain why a post-COVID cough can last so long and what you can do to feel better.
There are two groups in the outpatient studies. "One group does have to be actively infected, have to have a positive test, but not hospitalized," said Dr. Nathaniel Marchetti, Thoracic Medicine and Surgery. So that patient isn't terribly sick. "The other group would be someone who's not infected. We're trying to prevent an infection because they're in high risk because you know their spouse might be infected," said Dr. Marchetti. Someone in your household is infected but you are not. There is a one-time infusion drug and oral medications in those trials. To take part, you can reach out to T...